Wang_2024_Int.J.Surg.Case.Rep_115_109241

Reference

Title : Efgartigimod is a new option for the treatment of thymoma associated myasthenia gravis: A case report - Wang_2024_Int.J.Surg.Case.Rep_115_109241
Author(s) : Wang S , Wang Q , Jin L , Dong J , Ding J
Ref : Int J Surg Case Rep , 115 :109241 , 2024
Abstract : Wang_2024_Int.J.Surg.Case.Rep_115_109241
ESTHER : Wang_2024_Int.J.Surg.Case.Rep_115_109241
PubMedSearch : Wang_2024_Int.J.Surg.Case.Rep_115_109241
PubMedID: 38219512

Related information

Citations formats

Wang S, Wang Q, Jin L, Dong J, Ding J (2024)
Efgartigimod is a new option for the treatment of thymoma associated myasthenia gravis: A case report
Int J Surg Case Rep 115 :109241

Wang S, Wang Q, Jin L, Dong J, Ding J (2024)
Int J Surg Case Rep 115 :109241